A single-center experience of safety and effectiveness of adjustable intragastric balloon in patients with super obesity

Background: The Spatz3® Intragastric Adjustable Balloon (SAB) offers a novel approach to weight loss in super obese patients [body mass index (BMI) ≥50 kg/m2]. This study evaluates the safety, effectiveness, and predictors of success of SAB in this population. Methods: A retrospective study was cond...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed S. Khan, Adnan Alzanbagi, Abdulaziz Tashkhandi, Laeeque A. Qurashi, Aly ElBahrawy, AlWahhaj Khogeer, Ghadeer Alhazmi, Ghadeer Monshi, Mohammed K. Shariff
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-03-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Online Access:https://journals.lww.com/10.4103/sjg.sjg_272_24
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: The Spatz3® Intragastric Adjustable Balloon (SAB) offers a novel approach to weight loss in super obese patients [body mass index (BMI) ≥50 kg/m2]. This study evaluates the safety, effectiveness, and predictors of success of SAB in this population. Methods: A retrospective study was conducted at King Abdullah Medical City, Makkah, Saudi Arabia, involving 94 patients with SAB implantation. Weight loss metrics (%EWL, %TBWL), complications, and predictors of adverse events were analyzed. Results: Eleven patients required early SAB removal due to severe symptoms. Complications included gastrointestinal bleeding (3.2%), gastric ulcer/erosion (27.7%), and deflation (5.3%). Significant weight loss was observed at 6 and 12 months. The mean absolute weight loss was 22.03 kg at 12 months, with %EWL of 19.27%. Early weight loss at 3 months predicted long-term success. SAB adjustments did not significantly impact outcomes. Post SAB, 57% of patients proceeded to laparoscopic sleeve gastrectomy (LSG) with rare postoperative complications (2.9%). Conclusion: SAB is safe and effective for patients with BMI ≥50 kg/m2, achieving significant weight loss at 12 months. Early weight loss predicts long-term success, and subsequent LSG can be performed without significant complications. Further research should explore long-term outcomes and comparative analyses.
ISSN:1319-3767
1998-4049